Cairo Pharmaceuticals (CPCI.CA) - Board of Directors' Decisions
Company Name : Cairo Pharmaceuticals
ISIN Code : EGS38391C016
Reuters Code : CPCI.CA
Content :
The Board of Directors' decisions held on 03/12/2025 including the unaudited financial results for the ended period on 30/09/2025.
The BoD Decisions (756 KB)
ISIN Code : EGS38391C016
Reuters Code : CPCI.CA
Content :
The Board of Directors' decisions held on 03/12/2025 including the unaudited financial results for the ended period on 30/09/2025.
The BoD Decisions (756 KB)
Comments